Development of Novel NKp46-based Chimeric Antigen Receptors for Cancer Immunotherapy
Bo Zou(Jilin University), Qibin Liao(Shanghai Public Health Clinical Center), Lin Qi(Sun Yat-sen University), Mei‐Yan Xu, Wenyan Xu(State Key Laboratory of Respiratory Disease), Xiaohua Tan(Hangzhou Normal University)
Cited by 0
Related Papers
PLAG1 fusion oncogenes in lipoblastoma.
|PubMed|2000|234
Dynamic Behavior of Molecular Switches in Crystal under Pressure and Its Reflection on Tactile Sensing
|Journal of the American Chemical Society|2014|220
Gastroenteritis Outbreaks Caused by Norovirus GII.17, Guangdong Province, China, 2014–2015
|Emerging infectious diseases|2015|182
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR
|EBioMedicine|2020|181
Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test
|Annals of Translational Medicine|2020|161